Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines

Blood

Volumn 96, Issue 5, 2000, Pages 1873-1878

  Weitzmann, M N ^a   Cenci, S ^a   Rifas, L ^a   Brown, C ^a   Pacifici, R ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 7;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0034284296     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.5.1873     Document Type: Article

References (28)

1. Effects of T cell adoptive transfer into nude mice on alveolar bone resorption induced by endotoxin
2. Histopathological study of the role of CD4- and CDS-positive T cells on bone resorption induced by Escherichia coli endotoxin
3. A role for CD8+ T lymphocytes in osteoclast differentiation in vitro
4. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
5. Activated T lymphocytes support osteoclast formation in vitro
6. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
7. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
8. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
9. Elevated circurating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis
10. Detection of cytokine mRNA in human, articular cartilage from patients with rheumatoid arthritis and osteoarthritis by reverse transcriptase-polymerase chain reaction
11. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function Similarity to estrogen deficiency
12. Exogenous interleukin 7 as a proliferative stimulant of early precursor B cells in mouse bone marrow: Efficacy of IL-7 injection, IL-7 infusion and IL-7-anti-IL-7 antibody complexes
13. Interleukin 7 is a T-cell growth factor
14. A novel pathway to osteoclasts from B220-positive cells: Implications in estrogen deficiency osteoporosis [abstract]
15. Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells
16. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: Evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids
17. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival
18. Regulation of human T cell proliferation by IL-7
19. A human homolog of the 150 kD avian osteoclast membrane antigen related to superoxide dismutase and essential for bone resorption is induced by developmental agents and opposed by estrogen in FLG 29.1 cells
20. Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes
21. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures
22. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact
23. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis
24. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production
25. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1
26. Vascular endothelial growth factor can substitute for macrophage corony-stimulating factor in the support of osteoclastic bone resorption
27. Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation